To advance cancer care globally To advance cancer care globally Ichnos Glenmark Innovation (IGI), our wholly owned subsidiary, is working towards delivering treatments for hematalogical malignancies and solid tumors. Our research and focus on targeted therapies, immuno-oncology assets, biologics combined with global partnerships have helped us accelerate access to transformational therapies across the globe to […]